ConforMIS, Inc. is a medical technology company. The Company uses its
iFit Image-to-Implant technology platform to develop, manufacture and
sell joint replacement implants that are individually sized and shaped,
to fit each patient's anatomy. It is engaged in offering a line of
customized knee implants designed to restore the natural shape of a
patient's knee. The Company has sold over 30,000 knee implants in the
United States and Europe. It also launched iTotal PS, the Company’s
posterior-stabilized total knee replacement implant, which addresses the
largest segment of the knee replacement market. The Company’s products
are available in the United States, Germany and the United Kingdom. Its
products are offered to orthopedic surgeons, hospitals and other medical
facilities and patients. The Company’s iFit technology platform
includes three elements: iFit Design, iFit Printing and iFit
Just-in-Time Delivery.
There are 5 analysts who currently follow this stock, 4 have a BUY rating and 1 an OUTPERFORM.
ConforMIS Inc (NASDAQ:CFMS) is consolidating nicely between 17/19. Worth watching for a breakout. Stop 16.72
No comments:
Post a Comment